Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane in congenital idiopathic and acquired nystagmus
2007-002595-34Phase 2Completed
- Sponsor
- Merz
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neramexane in congenital idiopathic nystagmus (CIN) and Acquired nystagmus (2 arms), sponsored by Merz. Started Jan 2008; status: completed.
02
Drugs
neramexane
03
Conditions
congenital idiopathic nystagmus (CIN)Acquired nystagmus
Beyond the preview
Go deeper on 2007-002595-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002595-34.